Patent ID: 7285533
Filing Date: 2007-10-23
Classification: A01K,A61K,A61P,C07K,Y10S

Abstract:
1. A method of treating a mammal having ovarian cancer, comprising administering to the mammal Apo-2 ligand polypeptide in an amount effective to induce cell death in the mammal's ovarian cancer cells, wherein said Apo-2 ligand polypeptide is selected from the group consisting of: (a) a polypeptide comprising amino acid residues 114-281 of (b) a polypeptide consisting of amino acid residues 114-281 of (c) a polypeptide consisting of amino acid residues 1-281 of (d) a polypeptide which is a fragment of (a), (b) or (c).